Multicenter Real-World Registry of Anifrolumab (ANIFRO-REU) in Systemic Lupus Erythematosus: Effectiveness in Patients with Articular and Cutaneous Manifestations with up to 12 Months of Follow-up (ACR Convergence 2026) - Sep 8, 2026 - Abstract #2215; Pres time: Nov 10, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
Clinical • Real-world • Real-world evidence • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
|